J
James Geraghty
Researcher at European Institute of Oncology
Publications - 39
Citations - 2539
James Geraghty is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 9, co-authored 20 publications receiving 2446 citations.
Papers
More filters
Journal ArticleDOI
Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Umberto Veronesi,Giovanni Paganelli,Viviana Galimberti,Giuseppe Viale,Stefano Zurrida,Marilia Bedoni,Alberto Costa,Concetta De Cicco,James Geraghty,Alberto Luini,Virgilio Sacchini,Paolo Veronesi +11 more
TL;DR: Patients without clinical involvement of the axilla should undergo sentinel-node biopsy routinely, and may be spared complete axillary dissection when the sentinel node is disease-free, and thereby provide important information about the status of axillary nodes.
Journal ArticleDOI
Sentinel‐Node Biopsy to Avoid Axillary Dissection in Breast Cancer with Clinically Negative Lymph‐Nodes
Shahla Masood,Umberto Veronesi,Giovanni Paganelli,Viviana Galimberti,Giuseppe Viale,Stefano Zurrida,Marilia Bedoni,Alberto Costa,Concetta De Cicco,James Geraghty,Alberto Luini,Virgilio Sacchini,Paolo Veronesi +12 more
TL;DR: In the large majority of patients with breast cancer, lymphoscintigraphy and γ-probe-guided surgery can be used to locate the sentinel node in the axilla, and thereby provide important information about the status of axillary nodes.
Journal ArticleDOI
Pretargeting strategies for radio-immunoguided tumour localisation and therapy
H.S. Stoldt,F. Aftab,Marco Chinol,Giovanni Paganelli,Fabrizio Luca,Alessandro Testori,James Geraghty +6 more
TL;DR: Before pretargeting strategies are applied clinically, a thorough understanding of these systems is required and forms the backbone of this report.
Journal ArticleDOI
Adenomatous polyposis coli and translational medicine
TL;DR: Vasen et al. as mentioned in this paper investigated the possibility that the site of the mutation in the adenomatous polyposis coli (APC) gene may assist in the choice of surgical procedure, and found that further surgery, needed for recurrent polyps or rectal cancer, was greater in patients with mutations in the region after codon 1250 than in those with mutations before this codon.
Journal ArticleDOI
Sentinel node localization in primary melanoma: learning curve and results.
Alessandro Testori,Mirco Bartolomei,Chiara Maria Grana,Maura Mezzetti,Marco Chinol,Giovanni Mazzarol,I. Lazzari,Giovanni Paganelli,James Geraghty,Bruno Andreoni,Umberto Veronesi +10 more
TL;DR: SN biopsy should be performed by surgeons and nuclear medicine doctors in co-operation, both methods being adopted simultaneously to reduce the percentage of procedure failures.